写真:内子の白壁

論文集
Collected Papers

記事一覧

  • 越智博文
    多発性硬化症の早期診断・早期治療・地域連携.
    クリニシアン 2019; 670:38-44.

  • 越智博文
    多発性硬化症とスポーツ・運動.
    BRAIN and NERVE:神経研究の進歩 2019; 71:143-152.

  • 越智博文
    多発性硬化症と認知症.
    Dementia Japan 2019; 33:176-189.

  • 越智博文
    多発性硬化症の2017年版McDonald診断基準改訂のポイントは?症候性病変,皮質病変,脳脊髄液オリゴクローナルバンドの取り扱いが変更となった(Q&A).
    日本医事新報 2019; 4973:58

  • 越智雅之
    難渋症例から学ぶ診療のエッセンス:薬剤性認知障害を呈した肝硬変症.
    日本医事新報 2019; 4990:12-13.

  • 越智雅之
    各科におけるステロイド療法のノウハウ 神経内科.
    臨牀と研究 2019; 96:30-32.

  • Takeuchi F, Akiyama M, Matoba N, Katsuya T, Nakatochi M, Tabara Y, Narita A, Saw WY, Moon S, Spracklen CN, Chai JF, Kim YJ, Zhang L, Wang C, Li H, Li H, Wu JY, Dorajoo R, Nierenberg JL, Wang YX, He J, Bennett DA, Takahashi A, Momozawa Y, Hirata M, Matsuda K, Rakugi H, Nakashima E, Isono M, Shirota M, Hozawa A, Ichihara S, Matsubara T, Yamamoto K, Kohara K, Igase M, Han S, Gordon-Larsen P, Huang W, Lee NR, Adair LS, Hwang MY, Lee J, Chee ML, Sabanayagam C, Zhao W, Liu J, Reilly DF, Sun L, Huo S, Edwards TL, Long J, Chang LC, Chen CH, Yuan JM, Koh WP, Friedlander Y, Kelly TN, Bin Wei W, Xu L, Cai H, Xiang YB, Lin K, Clarke R, Walters RG, Millwood IY, Li L, Chambers JC, Kooner JS, Elliott P, van der Harst P; International Genomics of Blood Pressure (iGEN-BP) Consortium, Chen Z, Sasaki M, Shu XO, Jonas JB, He J, Heng CK, Chen YT, Zheng W, Lin X, Teo YY, Tai ES, Cheng CY, Wong TY, Sim X, Mohlke KL, Yamamoto M, Kim BJ, Miki T, Nabika T, Yokota M, Kamatani Y, Kubo M, Kato N.
    Interethnic analyses of blood pressure loci in populations of East Asian and European descent.
    Nat Commun 2018; 9:5052

  • Kawakami H, Ogimoto A, Tokunaga N, Nishimura K, Kawakami H, Higashi H, Lio C, Kono T, Aono J, Uetani T, Nagai T, Inoue K, Suzuki J, Ikeda S, Okura T, Ohyagi Y, Tabara Y, Higaki J.
    A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
    Int Heart J 2018; 59:531-541.

  • Okada Y, Ochi H, Fujii C, Hashi Y, Hamatani M, Ashida S, Kawamura K, Kusaka H, Matsumoto S, Nakagawa M, Mizuno T, Takahashi R, Kondo T.
    Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
    J Autoimmun 2018; 88:103-113.

  • Li G, Yamasaki R, Fang M, Masaki K, Ochi H, Matsushita T, Kira JI.
    Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Sci Rep 2018; 8:1933-1949.

  • Hiramatsu K, Hase M, Ochi H.
    Insights on diagnosis and therapeutic decision-making patterns for multiple sclerosis treatment: cross-sectional opinion survey results from Japanese neurologist.
    Mult Scler Demyelinating Disord 2018; 3:4-15.

  • Ochi H, Niino M, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Ling Y, Torii S.
    72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Analysis of the Randomized, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
    Advances in Therapy. 2018; 35:1598-1611.